Overview Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer Status: Completed Trial end date: 2009-04-01 Target enrollment: Participant gender: Summary Phase 2 study to investigate the efficacy and tolerability of epothilone ZK 219477 in patients with stage IIIb or stage IV non-small-cell lung cancer. Phase: Phase 2 Details Lead Sponsor: BayerTreatments: EpothilonesSagopilone